January 2018

Second-Line Chemotherapy Doublet Proves Noninferior to FOLFIRI in mCRC

January 12, 2018

Clinical Articles

According to the results of the randomized phase III AXEPT clinical trial, a chemotherapy doublet has proved noninferior to treatment with standard FOLFIRI (folinic acid [leucovorin], fluorouracil [5-FU], and irinotecan) for patients with previously treated metastatic colorectal cancer (mCRC).1

Taking on the Hospital/Community Practice Cost Differential

January 24, 2018

Clinical Articles

Just as CMS moves ahead with payment reforms designed to reduce the total cost of hospital care, results from a new study show that cancer treatment costs remain significantly lower at community oncology clinics compared with hospitals.

Organizing Faster Care for Urgent Lung Cancer Cases

January 15, 2018

Clinical Articles

Improving outcomes for disadvantaged patients with lung cancer has been a priority for over 5 years at Mary Bird Perkins-Our Lady of the Lake Cancer Center in Baton Rouge, Louisiana.